Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6–7 Months: A Phase 4, Randomized, Controlled Trial

Objective: To assess the immunogenicity and safety of the enterovirus 71 vaccine (Vero cell) (EV71 vaccine) and trivalent split-virion influenza vaccine (IIV3). Methods: Healthy infants aged 6–7 months were recruited from Zhejiang Province, Henan Province, and Guizhou Province and randomly assigned...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yanhui, Guo, Xue, Zhang, Min, Chen, Yaping, Zhang, Yanyang, Yu, Xiaoqing, Luo, Linyun, Chen, Haiping, Xu, Weichai, Liu, Haibo, Wu, Lixia, Hou, Renwu, Ma, Yong, Long, Lin, Ruan, Jiewei, Chen, Wei, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146551/
https://www.ncbi.nlm.nih.gov/pubmed/37112774
http://dx.doi.org/10.3390/vaccines11040862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146551/
https://www.ncbi.nlm.nih.gov/pubmed/37112774
http://dx.doi.org/10.3390/vaccines11040862

Ejemplares similares